DXCM vs BIIB
Dexcom vs Biogen — AI-powered side-by-side comparison
| Metric | DXCM | BIIB |
|---|---|---|
| AI Score | 57 | 61 |
| Price | $83.46 | $202.89 |
| P/E Ratio | 32.22× | 35.73× |
| ROE | 0.3% | 0.1% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.6% | 0.7% |
| Debt / Equity | 0.51× | 0.44× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 77.2 | 48.3 |
| Beta | 1.4526 | 0.158 |
| Expected Upside | +5.8% | +1.4% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
DXCM Full Analysis
BIIB Full Analysis